Science Business Announcements

Researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago have found a way forward in designing polymers by combining modeling and machine learning.

C-Path and NORD® hosted the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) 2020 Virtual Workshop on Monday, October 19. The platform, funded by a cooperative agreement through the U.S. Food and Drug Administration (FDA), serves as a centralized and standardized infrastructure to support data sharing and data analysis to aid in the understanding of rare diseases.

The Salk Institute and BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced a three-year collaboration agreement formed to advance cutting-edge academic discoveries in genetically driven diseases toward therapeutic applications. Under the partnership, BridgeBio will help fund research programs from Salk's world-renowned innovative cancer research, with the eventual goal of developing new therapeutics for patients in need.

Nonprofit publisher Annual Reviews is pleased to announce that the 2020 volumes of the Annual Review of Environment and Resources and the Annual Review of Nuclear and Particle Science have been converted from gated to open access. All articles in these volumes are published under a CC BY license and the back volumes, dating from 1976 and 1952, respectively, are now freely available. These are the final two journals included in the 2020 pilot program for Subscribe to Open.

Temple University Hospital has treated the first patient in a multicenter international clinical trial utilizing the RejuvenAir® System for the treatment of patients suffering from moderate to severe COPD with chronic bronchitis. Chronic bronchitis is characterized by a productive cough for months or years. Dr. Gerard Criner, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine and Director of the Temple Lung Center, is the overall principal investigator.

The increase in remote work and e-learning sparked by the COVID-19 pandemic means more people are reading in digital formats. But the technology doesn't lend itself easily to help enhance reading speed or comprehension. Other than changing font size and background lighting, digital readers are left with few options. That's why the University of Central Florida is partnering with global software company Adobe and others to improve the technology.